Small Molecule Medicinal Chemistry (eBook)

Strategies and Technologies
eBook Download: PDF
2015 | 1. Auflage
528 Seiten
Wiley (Verlag)
978-1-118-77157-0 (ISBN)

Lese- und Medienproben

Small Molecule Medicinal Chemistry -
Systemvoraussetzungen
132,99 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Stressing strategic and technological solutions to medicinal chemistry challenges, this book presents methods and practices for optimizing the chemical aspects of drug discovery. Chapters discuss benefits, challenges, case studies, and industry perspectives for improving drug discovery programs with respect to quality and costs. Focuses on small molecules and their critical role in medicinal chemistry, reviewing chemical and economic advantages, challenges, and trends in the field from industry perspectives Discusses novel approaches and key topics, like screening collection enhancement, risk sharing, HTS triage, new lead finding approaches, diversity-oriented synthesis, peptidomimetics, natural products, and high throughput medicinal chemistry approaches Explains how to reduce design-make-test cycle times by integrating medicinal chemistry, physical chemistry, and ADME profiling techniques Includes descriptive case studies, examples, and applications to illustrate new technologies and provide step-by-step explanations to enable them in a laboratory setting

Werngard Czechtizky is the Head of Medicinal Chemistry of the German Hub of Sanofi, based in Frankfurt, Germany. She has wide experience in lead generation and lead optimization for central nervous system, cardiovascular and diabetes targets, and her teams have been responsible for a number of leads and clinical candidates in these areas over the last years. She was educated at ETH Zürich and Harvard University, USA. Peter Hamley is the global head of External Innovation and Sourcing for chemistry, computational chemistry, and screening technologies at Sanofi, based in Frankfurt, Germany. He spent ten years at AstraZeneca in the United Kingdom, and then moved to Sanofi as a medicinal chemistry leader, building their automated chemistry capabilities and natural product technology. He was educated at Imperial College, London, the University of Cambridge and the University of Pennsylvania.

"This book describes a large variety of methodologies that are employed in drug discovery and early development. The subjects covered range from the design and administration of chemical libraries, access to new chemical scaffolds and chemical diversity, to characterization of target binding and ADME profiling methods. While the book focuses on traditional small-molecule medicinal chemistry, an outlook to non-traditional targets such as protein-protein interactions and imaging applications is also provided. Most of the authors have a background in the pharmaceutical industry. The book therefore allows an insight into laboratories that are less prone to publish their experiences than their academic counterparts, and the trends and observations which accumulate over the years. In addition, particularly the academic reader is presented with sometimes refreshingly independent views on certain popular topics in medicinal chemistry and chemical biology that have reached "nuisance" status in recent years. For example, the discussion on "hit triage" contains a wide range of literature reference points beyond the currently over-debated assay-interference compounds that will allow the interested reader to obtain a well-balanced view. For an academic who is heavily involved in teaching duties, the book offers numerous highly useful overviews, such as the development chart of combinatorial chemistry methods. Although the heydays of combi-chem have long passed, the concept has remained an important addition to the toolbox of medicinal

chemistry, also in academic laboratories. Fittingly, one of the following chapters provides a review of multicomponent

reactions. This chapter is filled with numerous highly appreciated figures that collect and demonstrate the broad chemical diversity which is accessible via traditional and recently developed multicomponent reactions, a real treasure chest that will certainly be useful in teaching and research. There are some weaker parts in the book. This is, for example, the natural

products chapter, which starts with a reference to a "famous", highly biased publication that "proves" the importance of

natural products by classifying, for example, purely synthetic ATP-competitive kinase inhibitors as somehow natural-product- derived. This is followed by a long table that is mostly, and not surprisingly, composed of antibiotics and steroids of semisynthetic origin. Next, however, appear some interesting examples of such semi-synthetic strategies, which will be highly instructive for students and practitioners of medicinal chemistry. And these latter examples clearly demonstrate that it is actually not necessary to make natural products appear more important by creating just the right definition for terms such as "natural-product-derived". Somewhat annoying is the use of an insert for color figures, requiring frequent "lookups", particularly since the captions are not provided along with the color figures. However, this technical aspect is really minor, and may have been necessary to keep the price of the book at a reasonable level--about £130, which could also be in the range of interested students. For the reviewer, selected fragments of the book will certainly be integrated into the teaching curriculum, and the book will be recommended for students at all levels. "
(Prof. Christian Klein Heidelberg University - ChemMedChem, July 2017)

Erscheint lt. Verlag 21.9.2015
Sprache englisch
Themenwelt Naturwissenschaften Chemie Technische Chemie
Technik
Schlagworte Biochemie • biochemistry • Biowissenschaften • Chemie • Chemistry • Life Sciences • Medizinische Chemie • Organic Chemistry • Organische Chemie • Pharmaceutical & Medicinal Chemistry • Pharmazeutische u. Medizinische Chemie
ISBN-10 1-118-77157-5 / 1118771575
ISBN-13 978-1-118-77157-0 / 9781118771570
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 25,2 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich

von Manfred Baerns; Arno Behr; Axel Brehm; Jürgen Gmehling …

eBook Download (2023)
Wiley-VCH GmbH (Verlag)
84,99